Trabectedin Production Cost Reports

The report provides a detailed analysis essential for establishing a Trabectedin production plant. It encompasses all critical aspects necessary for Trabectedin production, including the cost of Trabectedin production, Trabectedin plant cost, Trabectedin production costs, and the overall Trabectedin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Trabectedin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Trabectedin is a chemo drug that binds to cancer cells' DNA, disrupting cell division, transcription, and repair. It also calms the area around tumours to slow their spread. It is approved by the FDA for advanced liposarcoma and leiomyosarcoma (types of soft tissue sarcomas). It is effective in patients who have already tried anthracycline chemo like doxorubicin. It is also used in similar sarcomas where standard drugs have failed, along with relapsed ovarian cancer when paired with liposomal doxorubicin.

It is used to manage breast, lung, prostate, stomach, endometrial cancers, Ewing's sarcoma, and rare ovarian types like clear cell, in combination with drugs like irinotecan, cisplatin, or doxorubicin. It is given as an IV infusion every 3 weeks after liver tests and dexamethasone to protect against side effects.

The market for Trabectedin is driven by rising cases of soft tissue sarcomas and ovarian cancers globally. The improved cancer screening and diagnosis, investments in medical facilities, and growing demand in hospital pharmacies and specialised cancer centres contribute to its market growth.

The research into new drug combinations, formulations, and next-generation therapies boosts its market growth. Also, growth in the production of generics after patent expirations affects their prices and availability oncology field. The industrial Trabectedin procurement is affected by competitive tenders and long-term rate contracts (like those issued by institutions like AIIMS and ESIC). Other factors, like cost-effectiveness analyses, quality-adjusted life year assessments for sarcoma treatment, limited availability through specialised importers, etc., affect its sourcing strategies.

Raw Material for Trabectedin Production

According to the Trabectedin production plant project report, the key raw materials used in the production of Trabectedin include Safracin B-Silver Nitrate-Acetonitrile.

Production Process of Trabectedin

The extensive Trabectedin production cost report consists of the following major industrial production process:

1. From Safracin B: The Trabectedin production involves a multi-step semisynthetic process. The process starts from safracin B, followed by chemical modifications including Pictet-Spengler cyclisation. This is followed by aldol condensations and reductions. Finally, high-yield cyclisation takes place using silver nitrate in acetonitrile/water under an inert atmosphere at room temperature to give pure Trabectedin as the final product.

Trabectedin is a light yellow to yellow solid with molecular formula C39H43N3O11S and a molecular weight of 761.84 g/mol. It has seven chiral centres, eight fused rings, including a 10-membered heterocyclic ring with a cysteine residue. It shows slight solubility in chloroform and methanol, and binds covalently to DNA's minor groove at guanine N2. It forms interstrand crosslinks via hydrogen bonds and van der Waals forces. It works as an iminium intermediate from carbinolamine dehydration for DNA alkylation, disrupting transcription factors, cell proliferation, and inducing DNA curvature toward the major groove.